Compare Norfolk Southern Corporation (NSC) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Norfolk Southern Corporation vs ResMed Inc. — how do they compare? Norfolk Southern Corporation trades at $333 (market cap $75.23B), while ResMed Inc. trades at $197.45 (market cap $28.81B). The key difference: Norfolk Southern Corporation is far larger — about 2.6× ResMed Inc.'s market cap, and Norfolk Southern Corporation pays the higher dividend (1.61%). Which is the better fit depends on your goals.
| NSC | RMD | |
|---|---|---|
Market Cap | $75.23B | $28.81B |
Sector | Technology | Health |
52-Week High | $340.16 | $293.73 |
52-Week Low | $272.35 | $182.82 |
Enterprise Value | $90.99B | $27.99B |
Dividend Yield | 1.61% | 1.21% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Norfolk Southern Corporation
Norfolk Southern Corporation is a major North American railroad company operating one of the largest freight rail networks in the eastern United States. The company transports a diverse range of commodities, including coal, intermodal containers, and various industrial products. NSC is a critical link in the nation's supply chain, providing efficient, long-haul transportation services to and from ports and industrial centers.
Read more on NSC →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
